● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

GLAND

BSE
Gland Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE068V01023· Scrip: 543245
ENहिन्दीગુજરાતીमराठी
2,268.00
19.90 (+0.00%)
2026-06-10
BSE
2,268.00
19.90
+0.00%
1,5891,7781,9672,1562,34606-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open2,308.25
High2,338.80
Low2,256.30
Prev Close2,287.90
Volume9,896
Value₹2.3Cr
L: 2,256.30H: 2,338.80
Info
Face Value₹1
Listed2020-11-20
ISININE068V01023
SeriesA
BSE Scrip543245

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-1.55%
PAT+25.17%
EPS+25.08%
Profitability
Dividend
Growth-10.00%
TTM Revenue
₹5729 Cr
TTM EBITDA
₹1860 Cr
TTM PAT
₹704 Cr
TTM EPS
₹42.76
Rev/Share
₹347.7

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr386 Cr773 Cr1159 Cr1545 Cr23-0323-0623-0923-1224-0324-0624-0924-124.811.811.811.711.78.79.912.4
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-311384 Cr1143 Cr513 Cr299 Cr205 Cr12.42
2024-09-301406 Cr1209 Cr450 Cr257 Cr164 Cr9.93
2024-06-301402 Cr1235 Cr390 Cr218 Cr144 Cr8.73
2024-03-311537 Cr1281 Cr507 Cr298 Cr192 Cr11.68
2023-12-311545 Cr1299 Cr485 Cr283 Cr192 Cr11.65
2023-09-301373 Cr1137 Cr473 Cr290 Cr194 Cr11.78
2023-06-301209 Cr985 Cr399 Cr261 Cr194 Cr11.79
2023-03-31785 Cr656 Cr183 Cr111 Cr79 Cr4.78

Shareholding Pattern

CURRENT2026-03-31
51.8%PROMOTER
Promoter51.8%
FII7.3%
DII33.4%
Public48.2%
PROMOTER HOLDING TREND
51.8%24-0651.8%24-0951.8%24-1251.8%25-0351.8%25-0951.8%25-1251.8%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-14DividendDividend - Rs 18 Per Share
2024-08-16DividendAnnual General Meeting/Dividend - Rs 20 Per Share
2021-08-06Other Annual General Meeting

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-102,299.002,341.502,250.002,267.803.20L
2026-06-032,277.002,305.902,222.002,232.302.56L
2026-05-272,324.102,354.702,309.202,313.002.24L
2026-05-262,339.702,354.702,252.102,307.908.74L
2026-05-252,369.802,396.002,321.102,333.805.06L
2026-05-222,353.502,363.502,307.202,334.008.64L
2026-05-212,230.002,370.002,230.002,331.0010.19L
2026-05-202,232.902,295.102,201.902,221.8011.80L
2026-05-192,148.002,273.902,138.502,251.1023.57L
2026-05-182,122.002,207.002,034.002,156.6071.32L
2026-05-151,910.101,950.001,853.601,868.301.42L
2026-05-141,844.201,906.001,822.201,898.201.75L
2026-05-131,870.001,872.101,813.001,844.201.00L
2026-05-121,920.001,928.001,860.701,872.1090,163
2026-05-111,910.201,953.701,878.701,919.101.67L
2026-05-081,870.901,922.701,866.201,904.402.72L
2026-05-071,811.901,882.001,811.901,870.602.43L
2026-05-061,798.201,825.001,781.801,811.503.74L
2026-05-051,815.501,839.001,763.201,773.301.94L
2026-05-041,750.801,827.501,748.001,815.501.04L
2026-04-301,747.501,767.301,728.401,750.802.21L
2026-04-291,767.801,776.301,735.101,739.1037,857
2026-04-281,773.101,773.101,745.001,760.8080,928
2026-04-271,717.601,781.301,711.001,775.501.13L
2026-04-241,791.501,798.101,702.901,713.501.62L
2026-04-231,786.601,832.001,782.001,795.4055,778
2026-04-221,780.001,818.101,774.001,800.6091,491
2026-04-211,785.601,792.801,761.601,781.001.10L
2026-04-201,796.001,811.901,763.001,794.6096,610
2026-04-171,736.001,811.201,736.001,797.401.43L

Frequently Asked Questions

About

Gland Pharma Limited is an Indian-based manufacturer of generic injectables, specializing in sterile formulations, oncology, and ophthalmic products, with a focus on complex injectables and New Chemical Entities. The company operates globally, supplying to markets including the United States, Europe, and India, and is recognized as one of the world's fastest-growing generic injectable manufacturers.

BOARD OF DIRECTORS
Srinivas Sadu
Managing Director
DEPARTED
Essaji Goolam Vahanvati
Independent Director
Satyanarayana Murthy Chavali
Independent Director

Mutual Fund Holdings

4 funds · bar length = % to NAVBrowse all funds →
hdfc3 schemes
HDFC Mid Cap Fund
1.26%
₹10.7K Cr
HDFC Large and Mid Cap Fund
0.94%
₹2.4K Cr
HDFC NIFTY SMALLCAP 250 INDEX FUND
0.79%
₹4 Cr
baroda1 scheme
Baroda BNP Paribas Health and Wellness Fund
0.03%
₹15 Cr